SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GZTC
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: SONAR who wrote (4)8/12/1996 12:33:00 AM
From: Robert Cohen   of 752
 
It bounced down as a result of a three million share offering at $4.00 a share of which Genzyme bought I believe, 900,000 shares. The offering was completed I believe on August 5. Thereafter it bounced back up. It seems to me that GZTC has been making progress on all fronts. I suspect that its testing services section is about ready to be profitable. It seems to me a good place to throw some highly speculative money at.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News